Insulin Glargine (U-100) Vials and Ranibizumab Intraocular
Determining the interaction of Insulin Glargine (U-100) Vials and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Vials-Ranibizumab ophthalmic
- Insulin Glargine (U-100) Vials-Ranitidine
- Insulin Glargine (U-100) Vials-Ranitidine Capsule
- Insulin Glargine (U-100) Vials-Ranitidine Hydrochloride
- Insulin Glargine (U-100) Vials-Ranitidine Injection
- Insulin Glargine (U-100) Vials-Ranitidine Suspension
- Ranibizumab Intraocular-Insulin Glargine (U-300) Pens
- Ranibizumab Intraocular-Insulin glargine and lixisenatide
- Ranibizumab Intraocular-Insulin glargine and lixisenatide Subcutaneous
- Ranibizumab Intraocular-Insulin glargine, recombinant Subcutaneous
- Ranibizumab Intraocular-Insulin glulisine
- Ranibizumab Intraocular-Insulin Glulisine (Cartridges and Pens)